Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FBLN3 Protein (AA 26-213) (His tag)

This Recombinant FBLN3 protein is produced in Escherichia coli (E. coli).
Catalog No. ABIN7419628

Quick Overview for FBLN3 Protein (AA 26-213) (His tag) (ABIN7419628)

Target

See all FBLN3 Proteins
FBLN3 (Fibulin 3 (FBLN3))

Protein Type

Recombinant

Origin

  • 7
  • 3
  • 3
  • 1
  • 1
Human

Source

  • 5
  • 4
  • 2
  • 1
Escherichia coli (E. coli)

Application

Western Blotting (WB), SDS-PAGE (SDS), Positive Control (PC), Immunogen (Imm)

Purity

> 90 %
  • Protein Characteristics

    AA 26-213

    Purification tag / Conjugate

    This FBLN3 protein is labelled with His tag.

    Sequence

    Tyr26-Val213

    Characteristics

    Recombinant Fibulin 3 (FBLN3), Prokaryotic expression, Tyr26-Val213, N-terminal His Tag
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Isoelectric Point:

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

    Expiry Date

    12 months
  • Target

    FBLN3 (Fibulin 3 (FBLN3))

    Alternative Name

    Fibulin 3

    Background

    EFEMP1, DHRD, DRAD, FBNL, MLVT, MTLV, S1-5, EGF-Containing Fibulin-Like Extracellular Matrix Protein 1, Fibrillin-Like, Extracellular protein S1-5

    UniProt

    Q12805

    Pathways

    EGFR Signaling Pathway
You are here:
Chat with us!